Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Inventory (2018 - 2025)

Historic Inventory for Agios Pharmaceuticals (AGIO) over the last 7 years, with Q3 2025 value amounting to $32.0 million.

  • Agios Pharmaceuticals' Inventory rose 2120.78% to $32.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.0 million, marking a year-over-year increase of 2120.78%. This contributed to the annual value of $27.6 million for FY2024, which is 4476.83% up from last year.
  • According to the latest figures from Q3 2025, Agios Pharmaceuticals' Inventory is $32.0 million, which was up 2120.78% from $30.8 million recorded in Q2 2025.
  • Over the past 5 years, Agios Pharmaceuticals' Inventory peaked at $32.0 million during Q3 2025, and registered a low of $2.5 million during Q1 2022.
  • In the last 4 years, Agios Pharmaceuticals' Inventory had a median value of $19.1 million in 2023 and averaged $18.5 million.
  • Per our database at Business Quant, Agios Pharmaceuticals' Inventory surged by 35770.62% in 2023 and then soared by 2120.78% in 2025.
  • Over the past 4 years, Agios Pharmaceuticals' Inventory (Quarter) stood at $8.5 million in 2022, then surged by 124.63% to $19.1 million in 2023, then soared by 44.77% to $27.6 million in 2024, then grew by 16.0% to $32.0 million in 2025.
  • Its Inventory stands at $32.0 million for Q3 2025, versus $30.8 million for Q2 2025 and $29.6 million for Q1 2025.